The decline in fractures caused by osteoporosis has stagnated, leading bone experts to suspect a lack in osteoporosis diagnosis and treatment guideline adherence. To combat this, the American Society ...

WASHINGTON, May 9, 2012 – The Food and Drug Administration (FDA) announced today that physicians should reassess patients with osteoporosis who are being treated with a class of drugs called ...

The American Society for Bone and Mineral Research held its 30th annual meeting in Montreal between September 12 and 16. About 5,000 people attended, including roughly equal numbers of clinicians and ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The relative ...

MONTREAL -- Drug holidays among women receiving bisphosphonates markedly reduced the risk of atypical femur fractures, a researcher reported here. "Drug holidays are increasing being used as a method ...

Washington, DC – An international expert task force is calling on health care providers to aggressively identify and provide care for the millions of people who have suffered their first ...

Oral Presentation and Poster Sessions to Highlight Positive Phase 2 Results of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Ashleigh Palmer, Unigene's Chief Executive Officer, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare ...

The National Bone Health Alliance working group expanded criteria for the clinical diagnosis of osteoporosis to include T-score < 2.5 at the spine or hip; low-trauma hip fracture; low-trauma vertebral ...

JERUSALEM, June 26, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, announced that new data exploring the dual ...